-
Mashup Score: 0A Journey of Courage: Empowering Others with Gastric Cancer - 2 day(s) ago
During this Gastric Cancer Awareness Month (GCAM), watch Essie Graeber’s courageous journey through her diagnosis and treatment of gastric cancer.
Source: wwwext.amgen.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
This article is sponsored by Amgen.
Source: www.cancerhealth.comCategories: General Medicine News, PayerTweet-
The words “You have lung cancer” change everything. During #LCAM, we're honored to share Vickie’s story about finding hope and support after her diagnosis. Discover more in this #AmgenSponsored @cancerhealthmag article: https://t.co/Xqze0VmqKW https://t.co/U85WljkxkD
-
-
Mashup Score: 2
This article is sponsored by Amgen.
Source: www.cancerhealth.comCategories: General Medicine News, PayerTweet-
The words “You have lung cancer” change everything. During #LCAM, we're honored to share Vickie’s story about finding hope and support after her diagnosis. Discover more in this #AmgenSponsored @CancerHealth article: https://t.co/lrKZIP8j3H https://t.co/opPaaxohRS
-
-
Mashup Score: 5Expanding Innovation in BiTE® Technology for Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) - 6 day(s) ago
After decades of minimal advancements in the SCLC treatment landscape, there is now a new treatment option available for patients living with this advanced disease.
Source: www.amgen.comCategories: General Medicine News, PayerTweet-
Small cell lung cancer (#SCLC) presents unique treatment challenges. But there’s hope – innovative research is paving the way for novel therapies. 🔗 Learn more: https://t.co/PbFkq79Esc #LCAM https://t.co/S3XOGQdo9f
-
-
Mashup Score: 1Sponsored Advertising Content - The Power of Perseverance While Navigating Lung Cancer | Cancer Today - 10 day(s) ago
How the support of family and biomarker testing results helped one patient’s journey with cancer.
Source: www.cancertodaymag.orgCategories: General Medicine News, PayerTweet-
🔬Biomarker testing empowered Desiree & her care team to target her advanced NSCLC with a personalized treatment plan. Her advice? Be proactive, ask about biomarkers & #KnowYourLungs. Read her story in @CancerTodayMag: https://t.co/hkTEqIqhBq #LCAM #AmgenSponsored https://t.co/3nsKHWFanu
-
-
Mashup Score: 0
Learn how investigational DLL3 and T-cell engager technology together have the potential to address unmet needs in SCLC and high-grade neuroendocrine cancers.
Source: www.dll3possibilities.comCategories: General Medicine News, PayerTweet-
Small cell lung cancer (#SCLC) remains one of oncology’s toughest challenges. At @Amgen, we’re pioneering new approaches to bring patients additional options. 🔗Learn more at https://t.co/fjUmK25dgu #LCAM https://t.co/hyMiiZMrma
-
-
Mashup Score: 14Amgen GIFs on GIPHY - Be Animated - 16 day(s) ago
GIPHY is the platform that animates your world. Find the GIFs, Clips, and Stickers that make your conversations more positive, more expressive, and more you.
Source: giphy.comCategories: General Medicine News, PayerTweet-
✅ Fact: Lung cancer can affect anyone with lungs. At Amgen, we're dedicated to advancing all angles of care for those living with lung cancer. This #LCAM, let's share @Amgen's GIFs to boost awareness and inspire others to #KnowYourLungs: https://t.co/6UxzBQxmel https://t.co/G2CLyQmFmK
-
-
Mashup Score: 3Biomarker Testing in Personalized Cancer Medicine - 18 day(s) ago
Oncology has traditionally treated patients through combinations of surgery, chemotherapy, radiation therapy or immuno-oncology without the ability to consider the underlying genetics that individualize each patient’s cancer.
Source: www.amgen.comCategories: General Medicine News, PayerTweet-
#Biomarkers are crucial for optimal cancer care, says @FightCRC’s @AnjeeDavis. Learn how biomarker testing can improve 🔬detection 📊outcomes 🧬treatment decisions 🔗 https://t.co/PgMTHVcEzL https://t.co/BWuj01z2Jv
-
-
Mashup Score: 1Home - 1 month(s) ago
Learn more about gastric/GEJ cancer prevalence, prognosis, and the potential role of FGFR2b protein overexpression in tumorigenesis.
Source: www.fgfr2b.comCategories: General Medicine News, PayerTweet-
#GastricCancer HCPs: @Amgen’s Brian Lapham shares must-know facts about #FGFR2b – an exciting 🎯target for potential new therapies. 🔗Learn more at https://t.co/CBwpy1rTI8 https://t.co/I6sz43FWRS
-
-
Mashup Score: 2Platelet Disorder Support Association - Empowering ITP Patients - Pump It Up For Platelets! - 2 month(s) ago
Platelet Disorder Support Association – Empowering ITP Patients. Comprehensive information and support for those concerned about ITP, immune thrombocytopenia.
Source: pdsa.orgCategories: General Medicine News, PayerTweet-
A growing understanding of #ITP is making it easier to manage this challenging blood disorder. Join us as @Amgen and @PDSA_ITP support people with ITP by participating in a Pump It Up For Platelets! event near you: https://t.co/LeUUNcuttr #AmgenSponsored https://t.co/lWwEK6xAbf
-
🌟“No one needs to go through this alone.” During #GastricCancerAwarenessMonth, we’re honored to share Essie’s story – her empowering advice shines a light for others on this journey. 🔗Watch more from Essie, part of @StoCANcer’s 30 Stories in 30 Days: https://t.co/DugXovQuh9 https://t.co/SiPUEn6jsO